Toy Stock Downgraded to 'Underperform' After Toys 'R' Us Bankruptcy

Biogen stock was downgraded amid competition concerns

Managing Editor
Sep 21, 2017 at 10:20 AM
facebook twitter linkedin

Analysts are weighing in on pharma stock Biogen Inc (NASDAQ:BIIB), toymaker JAKKS Pacific, Inc. (NASDAQ:JAKK), and packaged foods concern General Mills, Inc. (NYSE:GIS). Here's a quick roundup of today's bearish brokerage notes on shares of BIIB, JAKK, and GIS.

Raymond James Downgrades Biogen Amid Drug Competition

Biogen stock is down 0.8% to trade at $315.83, after Raymond James downgraded the pharmaceutical issue to "market perform" from "strong buy." The brokerage cited competition from Roche's new drug as the primary reason for the downgrade. BIIB stock has added 22% year-to-date, and broke out towards the end of August, pushing past a long-term resistance level to touch a two-year high of $330 last Wednesday. However, analyst sentiment is evenly skewed toward the drug stock. Of the 18 brokerages that cover BIIB, nine rate it a "strong buy," while the other nine rate it a "hold."

Toys 'R' Us Bankruptcy Prompts Downgrade To JAKK Stock

JAKK stock is down 7.1% to trade at $2.93, after D.A. Davidson downgraded the toymaker to "underperform" from "neutral," while also cutting its price target to $2.25 from $3.75. The downgrade comes after Toys R Us filed for bankruptcy earlier this week, which weighed on other toy stocks. JAKK stock has shed 66% year-over-year, and fell to a record low $2.68 on Monday.

The shares could come under more pressure going forward, if analysts continue to trim their outlooks. As it stands now, the equity has an average 12-month price target of $4.15, representing 42% upside to current levels. Don't be surprise if additional price-target cuts come through on JAKKS Pacific. 

General Mills Stock Receives Two More Earnings-Induced Price-Target Cuts

General Mills gapped lower yesterday after the company reported worse-than-expected fiscal first-quarter earnings and lackluster sales. As such, GIS stock received two price-target cuts this morning to $58 and $57, from RBC and BMO, respectively.  The security, which is currently down 0.6% to trade at $51.84, fell to a two-year low of $50.40 yesterday, and has shed over 20% year-over-year.

In the options pits, traders have preferred puts over calls for some time now. GIS has a 50-day put/call volume ratio of 1.01 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which ranks 3 percentage points from a 52-week high. 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Stock Pick Report


Special Offers from Schaeffer's Trading Partners